Market Share of Global Spinal Muscular Atrophy Treatment Industry
The spinal muscular atrophy treatment market is moderately competitive and consists of several major players. With the increasing consolidations of various organizations and product recalls in the healthcare sector, it is expected to generate competitive rivalry among the key players in the future. Some of the major players of the market are Novartis AG, Biogen Inc., F. Hoffmann - La Roche Ltd, and Cytokinetics Inc.
Spinal Muscular Atrophy Treatment Market Leaders
-
Biogen
-
F. Hoffmann - La Roche Ltd
-
Cytokinetics, Inc.,
-
Novartis AG
-
Catalyst Pharmaceutical
*Disclaimer: Major Players sorted in no particular order
